Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in EXEL — Exelixis, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to EXEL Full portfolio

Position in EXEL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,616,145
+$3,864,518 QoQ
Shares Held
103,219
+152.7% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#163
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Derivatives in EXEL

reported options exposure · as of Jun 30, 2026
CallValue
$23,347,331
CallShares
429,100
PutValue
$16,529,758
PutShares
303,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. EXEL ranks #44 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in EXEL

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,616,145 103,219
2026-06-30 $16,529,758 303,800
2026-06-30 $23,347,331 429,100
2026-03-31 $18,365,498 428,200
2026-03-31 $1,751,627 40,840
2026-03-31 $19,879,515 463,500
2025-12-31 $803,009 18,321
2025-12-31 $14,301,729 326,300
2025-12-31 $24,759,567 564,900
2025-09-30 $1,800,680 43,600
2025-09-30 $24,139,850 584,500
2025-09-30 $27,295,170 660,900
2025-06-30 $702,943 15,947
2025-06-30 $17,464,496 396,200
2025-06-30 $25,641,336 581,700
2025-03-31 $21,254,844 575,700
2025-03-31 $1,501,942 40,681
2025-03-31 $11,437,816 309,800
2024-12-31 $695,537 20,887
2024-12-31 $14,249,070 427,900
2024-12-31 $15,084,900 453,000
2024-09-30 $12,899,745 497,100
2024-09-30 $3,053,302 117,661
2024-09-30 $18,401,145 709,100
2024-06-30 $1,560,473 69,447
2024-06-30 $10,280,025 457,500
2024-06-30 $7,127,484 317,200
2024-03-31 $9,812,355 413,500
2024-03-31 $5,474,511 230,700
2024-03-31 $2,397,394 101,028
2023-12-31 $4,412,000 183,910
2023-12-31 $6,196,617 258,300
2023-12-31 $8,559,632 356,800
2023-09-30 $15,408,575 705,198
2023-09-30 $3,000,005 137,300
2023-09-30 $8,126,015 371,900
2023-06-30 $3,518,151 184,100
2023-06-30 $15,173,051 793,985
2023-06-30 $894,348 46,800
2023-03-31 $14,538,516 749,022
2023-03-31 $4,029,516 207,600
2023-03-31 $5,679,366 292,600
2022-12-31 $6,361,464 396,600
2022-12-31 $3,984,336 248,400
2022-12-31 $2,189,732 136,517
2022-09-30 $4,105,024 261,800
2022-09-30 $3,719,107 237,188
2022-09-30 $8,807,456 561,700
2022-06-30 $4,643,005 223,007
2022-06-30 $4,199,394 201,700